# Nuclide record nct06860971 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06860971/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06860971", "NCT06860971" ;
  schema:name "A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma"@en ;
  schema:description "A phase 3 trial testing AL2846 in thyroid cancer, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06860971/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06860971> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/thyroid/> ;
  nuclide:drugs <https://nuclide.cc/drugs/al2846/> .